-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
-
Summary
-
Spruce Biosciences, Inc. quarterly/annual Revenues history and growth rate from Q1 2022 to Q3 2025.
- Spruce Biosciences, Inc. Revenues for the quarter ending September 30, 2025 was $0.000, a 100% decline year-over-year.
- Spruce Biosciences, Inc. Revenues for the twelve months ending September 30, 2025 was $697K, a 90.2% decline year-over-year.
- Spruce Biosciences, Inc. annual Revenues for 2024 was $4.91M, a 51.3% decline from 2023.
- Spruce Biosciences, Inc. annual Revenues for 2023 was $10.1M.
Revenues, Trailing 12 Months (USD)
Revenues, Quarterly (USD)
Revenues, YoY Quarterly Growth (%)
Revenues, Annual (USD)
Revenues, YoY Annual Growth (%)